[{"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-001", "question": "A 58-year-old woman with hypertrophic cardiomyopathy presents with progressive dyspnea and New York Heart Association class III symptoms despite maximum tolerated doses of metoprolol and verapamil. Echocardiography reveals a resting left ventricular outflow tract (LVOT) gradient of 85 mmHg, septal thickness of 22 mm, and systolic anterior motion of the mitral valve with moderate mitral regurgitation. She has no coronary artery disease on angiography. The septal perforator anatomy is suitable for intervention. Which of the following findings would most strongly favor surgical myectomy over alcohol septal ablation in this patient?", "options": ["Concomitant intrinsic mitral valve disease requiring repair", "Patient preference for less invasive procedure", "Presence of atrial fibrillation requiring maze procedure consideration", "Septal thickness greater than 20 mm", "Age greater than 55 years"], "answer": "A", "answer_index": 0, "explanation": "Surgical myectomy is preferred over alcohol septal ablation when concomitant cardiac pathology requiring surgical correction exists, such as intrinsic mitral valve disease (leaflet abnormalities, chordal pathology) needing repair or replacement. While septal thickness >30mm and unsuitable coronary anatomy favor surgery, 22mm thickness alone does not preclude ablation. Atrial fibrillation can be addressed with catheter ablation. Age and patient preference, while considerations, are not absolute indications for one approach over another.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: Hypertrophic cardiomyopathy with severe LVOT gradient, suitable septal perforator anatomy, no CAD, and NYHA class III symptoms despite maximal medical therapy. The question asks which finding most strongly favors surgical myectomy over alcohol septal ablation. The keyed answer (A) is correct: concomitant intrinsic mitral valve disease requiring repair is a well-established indication for surgery, as the procedure can address both pathologies. The other options are inferior: patient preference (B) is not a strong medical indication; atrial fibrillation (C) can often be managed percutaneously; septal thickness >20 mm (D) is not a contraindication to ablation (guidelines often cite >30 mm); and age >55 (E) is not a decisive factor. The item is logically valid and medically accurate. Minimal fix: None required; the item is sound.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: Hypertrophic cardiomyopathy with severe LVOT gradient, suitable septal perforator anatomy, no CAD, and NYHA class III symptoms despite maximal medical therapy. The question asks which finding most strongly favors surgical myectomy over alcohol septal ablation. The keyed answer (A) is correct: concomitant intrinsic mitral valve disease requiring repair is a well-established indication for surgery, as the procedure can address both pathologies. The other options are inferior: patient preference (B) is not a strong medical indication; atrial fibrillation (C) can often be managed percutaneously; septal thickness >20 mm (D) is not a contraindication to ablation (guidelines often cite >30 mm); and age >55 (E) is not a decisive factor. The item is logically valid and medically accurate. Minimal fix: None required; the item is sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-002", "question": "A 6-year-old boy presents with recurrent episodes of weakness and dark urine following viral illnesses. Laboratory studies during an acute episode show: serum creatine kinase 45,000 U/L, myoglobinuria, and non-ketotic hypoglycemia with inappropriately low free fatty acids. Acylcarnitine profile shows elevated C14:1 and C14:2 species. Genetic testing confirms compound heterozygous mutations in ACADVL. Which of the following dietary modifications is most critical for preventing future metabolic crises?", "options": ["Strict avoidance of medium-chain triglycerides", "Supplementation with odd-chain fatty acids", "Restriction of long-chain fatty acids with medium-chain triglyceride supplementation", "High-protein diet with branched-chain amino acid supplementation", "Carnitine supplementation with unrestricted fat intake"], "answer": "C", "answer_index": 2, "explanation": "ACADVL mutations cause very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency, a disorder of long-chain fatty acid oxidation. Management requires restriction of long-chain fatty acids (which cannot be metabolized) and supplementation with medium-chain triglycerides (MCTs), which bypass the defective enzyme and provide an alternative energy source. MCT avoidance would be harmful. Carnitine supplementation alone without dietary modification is insufficient, and high-protein diets do not address the underlying metabolic defect.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: recurrent weakness/dark urine after illness, CK 45k, myoglobinuria, non-ketotic hypoglycemia with low free fatty acids, elevated C14:1/C14:2 acylcarnitines, and confirmed ACADVL mutations (VLCAD deficiency). This pattern is classic for a long-chain fatty acid oxidation disorder. The logic is sound: the defective enzyme is VLCAD, which processes long-chain fatty acids, so they must be restricted. Medium-chain triglycerides (MCTs) bypass the block and are a critical energy source. Option C directly addresses this pathophysiology. Alternatives are incorrect: A (avoid MCTs) is harmful, B (odd-chain) is irrelevant, D (high-protein) is for urea cycle/aminoacidopathies, E (carnitine alone) is insufficient. No contradictions or missing details. Medical accuracy is high, aligning with standard management. Minimal fix: None required; item is clear and accurate.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1035)"}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-003", "question": "A 34-year-old woman with systemic lupus erythematosus on hydroxychloroquine and mycophenolate presents with acute onset severe headache, confusion, and seizures. Blood pressure is 168/102 mmHg. MRI brain shows bilateral posterior white matter T2/FLAIR hyperintensities without restricted diffusion. Lumbar puncture shows normal opening pressure, 8 WBC/μL (lymphocyte predominant), protein 52 mg/dL, and negative cultures. Anti-ribosomal P antibodies are positive. Which additional finding would most strongly suggest neuropsychiatric lupus rather than posterior reversible encephalopathy syndrome (PRES)?", "options": ["Presence of anti-dsDNA antibodies at high titer", "Low complement C3 and C4 levels", "Elevated CSF IgG index with oligoclonal bands", "Resolution of MRI findings with blood pressure control", "Concurrent lupus nephritis flare"], "answer": "C", "answer_index": 2, "explanation": "Elevated CSF IgG index with oligoclonal bands indicates intrathecal immunoglobulin synthesis, strongly supporting CNS inflammation from neuropsychiatric lupus (NPSLE) rather than PRES, which is a vasogenic edema syndrome without primary CNS inflammation. Anti-dsDNA antibodies and low complements indicate systemic lupus activity but don't differentiate CNS involvement. Resolution with BP control would actually favor PRES. Concurrent nephritis indicates systemic activity but doesn't confirm CNS-specific disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: acute neuropsychiatric symptoms in SLE, MRI showing posterior reversible encephalopathy syndrome (PRES)-like findings, positive anti-ribosomal P antibodies (associated with NPSLE), and CSF showing mild lymphocytic pleocytosis/elevated protein. The question asks which additional finding would most strongly differentiate neuropsychiatric lupus (NPSLE) from PRES. The keyed answer (C) is correct: elevated CSF IgG index with oligoclonal bands is a specific marker of intrathecal inflammation in NPSLE, not seen in PRES. Alternatives are correctly inferior: A and B indicate systemic activity, D favors PRES, and E indicates systemic flare but not CNS-specific pathology. The item is logically valid and medically accurate, with a clear single best answer supported by the rationale.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: acute neuropsychiatric symptoms in SLE, MRI showing posterior reversible encephalopathy syndrome (PRES)-like findings, positive anti-ribosomal P antibodies (associated with NPSLE), and CSF showing mild lymphocytic pleocytosis/elevated protein. The question asks which additional finding would most strongly differentiate neuropsychiatric lupus (NPSLE) from PRES. The keyed answer (C) is correct: elevated CSF IgG index with oligoclonal bands is a specific marker of intrathecal inflammation in NPSLE, not seen in PRES. Alternatives are correctly inferior: A and B indicate systemic activity, D favors PRES, and E indicates systemic flare but not CNS-specific pathology. The item is logically valid and medically accurate, with a clear single best answer supported by the rationale.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-004", "question": "A 52-year-old man with type 2 diabetes presents for evaluation of recurrent hypoglycemia occurring 3-4 hours postprandially. He underwent Roux-en-Y gastric bypass 2 years ago with 45 kg weight loss. During a symptomatic episode, laboratory studies show: glucose 38 mg/dL, insulin 45 μU/mL (elevated), C-peptide 8.2 ng/mL (elevated), proinsulin 22 pmol/L (elevated), and negative sulfonylurea screen. Calcium-stimulated angiography localizes insulin secretion to the body and tail of the pancreas. Which of the following is the most appropriate next step in management?", "options": ["Distal pancreatectomy", "Diazoxide therapy", "Octreotide therapy", "Dietary modification with acarbose", "Enucleation of insulinoma"], "answer": "D", "answer_index": 3, "explanation": "This presentation is classic for post-gastric bypass hyperinsulinemic hypoglycemia (nesidioblastosis/non-insulinoma pancreatogenous hypoglycemia syndrome). Unlike insulinoma, this involves diffuse islet cell hyperfunction. First-line management is dietary modification (low glycemic index, frequent small meals) combined with acarbose to slow carbohydrate absorption and blunt the exaggerated incretin response. Distal pancreatectomy is reserved for refractory cases. The diffuse localization on angiography and post-bypass context argue against focal insulinoma requiring enucleation.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: post-gastric bypass, recurrent postprandial hypoglycemia, elevated insulin/C-peptide/proinsulin, negative sulfonylurea screen, diffuse insulin secretion on angiography. These findings are classic for non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS). The logical issue is that the keyed answer (D, dietary modification with acarbose) is a first-line therapy, but the stem asks for the 'most appropriate next step' after diagnostic angiography has already localized the problem. In this specific clinical sequence, after confirming diffuse disease and excluding insulinoma, the most appropriate next step is typically a trial of medical therapy (e.g., diazoxide or octreotide) before considering surgery for refractory cases. Therefore, option B or C is more defensible as the immediate next step following the diagnostic test described. Medical accuracy is sound, but the sequencing logic is flawed. Minimal fix: Change the stem to 'Which of the following is the most appropriate initial management?' to justify the dietary/acarbose key.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: post-gastric bypass, recurrent postprandial hypoglycemia, elevated insulin/C-peptide/proinsulin, negative sulfonylurea screen, diffuse insulin secretion on angiography. These findings are classic for non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS). The logical issue is that the keyed answer (D, dietary modification with acarbose) is a first-line therapy, but the stem asks for the 'most appropriate next step' after diagnostic angiography has already localized the problem. In this specific clinical sequence, after confirming diffuse disease and excluding insulinoma, the most appropriate next step is typically a trial of medical therapy (e.g., diazoxide or octreotide) before considering surgery for refractory cases. Therefore, option B or C is more defensible as the immediate next step following the diagnostic test described. Medical accuracy is sound, but the sequencing logic is flawed. Minimal fix: Change the stem to 'Which of the following is the most appropriate initial management?' to justify the dietary/acarbose key.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-005", "question": "A 3-week-old male infant presents with poor feeding, lethargy, and hypotonia. He was born at term following an uncomplicated pregnancy. Physical examination reveals hepatomegaly, hypotonia, and macroglossia. Echocardiography shows severe biventricular hypertrophy with a left ventricular ejection fraction of 25%. Laboratory studies show elevated creatine kinase and AST. Urine organic acids are normal. Enzyme assay on dried blood spot shows markedly reduced acid alpha-glucosidase activity. Genetic testing confirms two pathogenic variants in GAA. Which of the following factors is most predictive of poor response to enzyme replacement therapy?", "options": ["Presence of cardiomyopathy at diagnosis", "Cross-reactive immunologic material (CRIM) negative status", "Age at diagnosis less than 1 month", "Elevated creatine kinase level", "Presence of macroglossia"], "answer": "B", "answer_index": 1, "explanation": "In infantile-onset Pompe disease, CRIM-negative status (complete absence of endogenous GAA protein) is the strongest predictor of poor response to enzyme replacement therapy (ERT) due to development of high-sustained antibody titers against the recombinant enzyme, which neutralize therapeutic effect. CRIM-negative patients require immune tolerance induction protocols. While early cardiomyopathy and young age at diagnosis indicate severe disease, CRIM-positive patients with these features can still respond well to ERT. Elevated CK and macroglossia are disease markers but not predictive of treatment response.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Infantile-onset Pompe disease confirmed by enzyme assay and genetics, with severe cardiomyopathy. The question asks for the factor most predictive of poor response to enzyme replacement therapy (ERT). CRIM-negative status is the established strongest predictor due to high-sustained antibody development. The other options (cardiomyopathy, age <1 month, elevated CK, macroglossia) are markers of disease severity but are not the primary determinant of immunologic response to ERT. No logical or medical inaccuracies are present. The item is well-specified and aligns with current management guidelines. Minimal fix: None required; the item is already unambiguous and accurate.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Infantile-onset Pompe disease confirmed by enzyme assay and genetics, with severe cardiomyopathy. The question asks for the factor most predictive of poor response to enzyme replacement therapy (ERT). CRIM-negative status is the established strongest predictor due to high-sustained antibody development. The other options (cardiomyopathy, age <1 month, elevated CK, macroglossia) are markers of disease severity but are not the primary determinant of immunologic response to ERT. No logical or medical inaccuracies are present. The item is well-specified and aligns with current management guidelines. Minimal fix: None required; the item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-006", "question": "A 67-year-old man with ischemic cardiomyopathy (LVEF 28%) and an implantable cardioverter-defibrillator presents after receiving three appropriate shocks for ventricular tachycardia over 24 hours despite amiodarone 400 mg daily. He is hemodynamically stable with blood pressure 102/68 mmHg. ECG shows sinus rhythm at 72 bpm with QTc 485 ms. Electrolytes and thyroid function are normal. Device interrogation confirms monomorphic VT at 188 bpm terminated by ATP and shocks. Which of the following is the most appropriate next step?", "options": ["Increase amiodarone to 600 mg daily", "Add mexiletine 200 mg three times daily", "Urgent catheter ablation of ventricular tachycardia", "Initiate dofetilide after appropriate QTc assessment", "Add ranolazine 500 mg twice daily"], "answer": "C", "answer_index": 2, "explanation": "This patient has electrical storm (≥3 sustained VT/VF episodes in 24 hours) refractory to amiodarone, which is a class I indication for urgent catheter ablation per current guidelines. Increasing amiodarone risks toxicity and QT prolongation. Adding mexiletine is reasonable for adjunctive therapy but does not address the substrate. Dofetilide is contraindicated with QTc >440ms in men and in the acute setting. Ranolazine has limited evidence for VT suppression. Catheter ablation targeting the VT substrate offers the best chance of preventing recurrent episodes.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: electrical storm (≥3 VT episodes/24h) despite amiodarone, hemodynamically stable, normal electrolytes/thyroid, monomorphic VT confirmed. The item clearly presents a guideline-supported class I indication for urgent catheter ablation in amiodarone-refractory VT storm. Alternatives are inferior: increasing amiodarone risks toxicity, mexiletine is adjunctive not primary, dofetilide contraindicated with prolonged QTc, ranolazine has limited evidence. No contradictions or missing details. Medical accuracy is consistent with current guidelines. Minimal fix: none required; item is already unambiguous and accurate.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: electrical storm (≥3 VT episodes/24h) despite amiodarone, hemodynamically stable, normal electrolytes/thyroid, monomorphic VT confirmed. The item clearly presents a guideline-supported class I indication for urgent catheter ablation in amiodarone-refractory VT storm. Alternatives are inferior: increasing amiodarone risks toxicity, mexiletine is adjunctive not primary, dofetilide contraindicated with prolonged QTc, ranolazine has limited evidence. No contradictions or missing details. Medical accuracy is consistent with current guidelines. Minimal fix: none required; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-007", "question": "A 14-year-old girl presents with 6 months of progressive proximal muscle weakness, heliotrope rash, and Gottron papules. She has difficulty climbing stairs and raising her arms. Laboratory studies show CK 4,200 U/L and positive anti-MDA5 antibodies. Chest CT reveals subtle ground-glass opacities in bilateral lower lobes. Pulmonary function tests show FVC 72% predicted and DLCO 58% predicted. Muscle biopsy shows perifascicular atrophy. Which of the following findings most significantly increases her risk of rapidly progressive interstitial lung disease?", "options": ["Elevated serum ferritin level", "Presence of mechanic's hands", "Positive anti-Jo-1 antibodies", "Calcinosis cutis on examination", "Elevated aldolase level"], "answer": "A", "answer_index": 0, "explanation": "Anti-MDA5 antibody-positive dermatomyositis is associated with rapidly progressive interstitial lung disease (RP-ILD), which can be fatal. Elevated serum ferritin is a biomarker strongly associated with RP-ILD severity and poor prognosis in anti-MDA5 positive patients, reflecting macrophage activation. Anti-Jo-1 is associated with ILD but typically a more chronic course. Mechanic's hands are associated with antisynthetase syndrome. Calcinosis and elevated aldolase are features of juvenile DM but not specific predictors of RP-ILD in anti-MDA5 disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: The patient has anti-MDA5+ dermatomyositis with ILD on imaging and PFTs. The question asks which finding most significantly increases risk of rapidly progressive ILD (RP-ILD). While elevated ferritin (A) is a prognostic marker in established RP-ILD, the strongest independent risk factor for developing RP-ILD in anti-MDA5+ DM is the presence of the anti-MDA5 antibody itself, which is already stated in the stem. Among the listed options, anti-Jo-1 (C) is incorrect for this phenotype, and mechanic's hands (B), calcinosis (D), and elevated aldolase (E) are not the most significant risk predictors. However, the literature strongly indicates that within anti-MDA5+ disease, the titer of anti-MDA5 and the presence of specific clinical features (like cutaneous ulceration) are more significant risk predictors than ferritin alone for the development (not just severity) of RP-ILD. The keyed answer (A) is not the most accurate or defensible best answer given the stem's framing. Main logical issue: The key does not match the single best answer supported by the clinical scenario and current evidence. Minimal fix: Change the key to the option representing the highest-risk cutaneous finding (e.g., 'cutaneous ulceration') or rephrase the question to ask for a prognostic marker for mortality in established RP-ILD, for which ferritin is more appropriate.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: The patient has anti-MDA5+ dermatomyositis with ILD on imaging and PFTs. The question asks which finding most significantly increases risk of rapidly progressive ILD (RP-ILD). While elevated ferritin (A) is a prognostic marker in established RP-ILD, the strongest independent risk factor for developing RP-ILD in anti-MDA5+ DM is the presence of the anti-MDA5 antibody itself, which is already stated in the stem. Among the listed options, anti-Jo-1 (C) is incorrect for this phenotype, and mechanic's hands (B), calcinosis (D), and elevated aldolase (E) are not the most significant risk predictors. However, the literature strongly indicates that within anti-MDA5+ disease, the titer of anti-MDA5 and the presence of specific clinical features (like cutaneous ulceration) are more significant risk predictors than ferritin alone for the development (not just severity) of RP-ILD. The keyed answer (A) is not the most accurate or defensible best answer given the stem's framing. Main logical issue: The key does not match the single best answer supported by the clinical scenario and current evidence. Minimal fix: Change the key to the option representing the highest-risk cutaneous finding (e.g., 'cutaneous ulceration') or rephrase the question to ask for a prognostic marker for mortality in established RP-ILD, for which ferritin is more appropriate.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-008", "question": "A 42-year-old woman presents to the emergency department with acute chest pain and dyspnea. She has a history of antiphospholipid syndrome with prior deep vein thrombosis, currently on warfarin with INR 2.8. ECG shows sinus tachycardia with new right bundle branch block. CT pulmonary angiography reveals bilateral pulmonary emboli with right ventricular dilation. Troponin I is 0.89 ng/mL. Blood pressure is 88/54 mmHg, heart rate 118 bpm. Despite 2 liters of crystalloid, blood pressure remains 84/52 mmHg. Which of the following is the most appropriate next step?", "options": ["Initiate unfractionated heparin infusion", "Administer systemic alteplase", "Perform catheter-directed thrombolysis", "Emergent surgical embolectomy", "Initiate norepinephrine and observe"], "answer": "B", "answer_index": 1, "explanation": "This patient has high-risk (massive) pulmonary embolism with hemodynamic instability (persistent hypotension despite fluid resuscitation) and RV dysfunction. Systemic thrombolysis with alteplase is the first-line treatment for hemodynamically unstable PE per guidelines, even in anticoagulated patients, as the mortality benefit outweighs bleeding risk. The therapeutic INR does not preclude thrombolysis in this life-threatening situation. Catheter-directed therapy or surgical embolectomy are alternatives if thrombolysis is contraindicated or fails. Simply adding vasopressors without addressing the obstruction is inadequate.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: acute PE with hemodynamic instability (persistent hypotension after fluids, SBP <90 mmHg), RV dilation, elevated troponin, and high-risk features despite therapeutic anticoagulation (INR 2.8). Systemic thrombolysis (B) is guideline-recommended first-line for massive PE with shock, overriding anticoagulation status. Alternatives: heparin (A) insufficient for shock; catheter-directed (C) or surgical (D) are for thrombolysis contraindications/failure; vasopressors alone (E) inadequate without reperfusion. No logical contradictions; key aligns with standard care. Medical accuracy is sound. Minimal fix: none needed; item is clear and accurate.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: acute PE with hemodynamic instability (persistent hypotension after fluids, SBP <90 mmHg), RV dilation, elevated troponin, and high-risk features despite therapeutic anticoagulation (INR 2.8). Systemic thrombolysis (B) is guideline-recommended first-line for massive PE with shock, overriding anticoagulation status. Alternatives: heparin (A) insufficient for shock; catheter-directed (C) or surgical (D) are for thrombolysis contraindications/failure; vasopressors alone (E) inadequate without reperfusion. No logical contradictions; key aligns with standard care. Medical accuracy is sound. Minimal fix: none needed; item is clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-009", "question": "A 28-year-old woman with Graves' disease treated with methimazole 30 mg daily for 8 weeks presents with fever (39.2°C), severe sore throat, and malaise for 2 days. Physical examination reveals pharyngeal erythema without exudate and no lymphadenopathy. Complete blood count shows WBC 1,200/μL with absolute neutrophil count 80/μL, hemoglobin 13.2 g/dL, and platelets 245,000/μL. Which of the following is the most appropriate immediate management?", "options": ["Discontinue methimazole and initiate propylthiouracil", "Discontinue methimazole, obtain blood cultures, and initiate broad-spectrum antibiotics with G-CSF", "Continue methimazole at reduced dose with close monitoring", "Discontinue methimazole and proceed with urgent thyroidectomy", "Discontinue methimazole and initiate lithium carbonate"], "answer": "B", "answer_index": 1, "explanation": "This patient has methimazole-induced agranulocytosis (ANC <500/μL), a rare but life-threatening complication occurring in 0.1-0.5% of patients, typically within the first 3 months. Management requires immediate discontinuation of the offending thionamide (cross-reactivity precludes switching to PTU), blood cultures, broad-spectrum antibiotics covering Pseudomonas given febrile neutropenia, and G-CSF to accelerate neutrophil recovery. Continuing or reducing methimazole is dangerous. Urgent thyroidectomy in an agranulocytic patient carries prohibitive infection risk. Alternative thyroid control can be achieved with beta-blockers, iodine, or lithium after stabilization.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: Graves' disease on methimazole for 8 weeks, fever, severe sore throat, profound neutropenia (ANC 80/μL). This defines febrile neutropenia secondary to drug-induced agranulocytosis. Main logical issue: None. Main medical accuracy issue: None; the management aligns with standard guidelines for febrile neutropenia and thionamide-induced agranulocytosis. Minimal fix: None required; the item is clear and accurate. The rationale correctly explains the need to stop methimazole (not switch to PTU due to cross-reactivity), obtain cultures, start empiric antibiotics, and use G-CSF, while ruling out other options.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 798)"}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-010", "question": "A 9-year-old boy with a history of Kawasaki disease at age 2 (treated with IVIG and aspirin, with documented giant coronary artery aneurysms) presents for routine cardiology follow-up. He is asymptomatic and active without limitations. Current medications include aspirin 81 mg daily and clopidogrel 75 mg daily. Echocardiography shows a 9 mm right coronary artery aneurysm (z-score +12) and 7 mm left anterior descending aneurysm (z-score +9). Stress MRI perfusion shows no inducible ischemia. Which of the following additional interventions is most strongly recommended based on current guidelines?", "options": ["Addition of warfarin with target INR 2.0-3.0", "Discontinuation of clopidogrel given no ischemia", "Annual exercise stress testing only", "Coronary CT angiography every 5 years", "Restriction from all competitive sports"], "answer": "A", "answer_index": 0, "explanation": "Giant coronary artery aneurysms (z-score ≥10 or absolute diameter ≥8mm) represent the highest risk category in Kawasaki disease and require triple antithrombotic therapy: aspirin, a second antiplatelet agent (clopidogrel), AND systemic anticoagulation with warfarin (target INR 2.0-3.0) or LMWH per AHA guidelines. This is due to high thrombotic risk within aneurysms. The absence of current ischemia does not reduce thrombotic risk. These patients require activity restriction from contact/collision sports but the antithrombotic intensification is the most critical missing intervention.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Giant coronary aneurysms (≥8 mm, z-scores +12 and +9) in an asymptomatic child on dual antiplatelet therapy. Main logical issue: The key (A) is not the single best answer. The most strongly recommended intervention per current AHA guidelines for giant aneurysms is triple antithrombotic therapy, which the patient is already receiving (aspirin, clopidogrel, and warfarin). The stem states he is on aspirin and clopidogrel only, so the missing intervention is indeed adding systemic anticoagulation (warfarin). However, option A is phrased as 'Addition of warfarin,' which is correct, but the rationale incorrectly states the patient is already on triple therapy. The key is correct, but the provided explanation contains a factual contradiction. Main medical accuracy issue: The answer explanation misstates the patient's current regimen, creating internal inconsistency. Minimal fix: Correct the answer explanation to state the patient is on dual antiplatelet therapy, and adding warfarin completes the required triple therapy.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Giant coronary aneurysms (≥8 mm, z-scores +12 and +9) in an asymptomatic child on dual antiplatelet therapy. Main logical issue: The key (A) is not the single best answer. The most strongly recommended intervention per current AHA guidelines for giant aneurysms is triple antithrombotic therapy, which the patient is already receiving (aspirin, clopidogrel, and warfarin). The stem states he is on aspirin and clopidogrel only, so the missing intervention is indeed adding systemic anticoagulation (warfarin). However, option A is phrased as 'Addition of warfarin,' which is correct, but the rationale incorrectly states the patient is already on triple therapy. The key is correct, but the provided explanation contains a factual contradiction. Main medical accuracy issue: The answer explanation misstates the patient's current regimen, creating internal inconsistency. Minimal fix: Correct the answer explanation to state the patient is on dual antiplatelet therapy, and adding warfarin completes the required triple therapy.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}]